Mersana Therapeutics, Inc. (MRSN)
收市後：
| 前收市價 | 3.1700 |
| 開市 | 3.1700 |
| 買盤 | 3.3300 x 200 |
| 賣出價 | 3.4100 x 200 |
| 今日波幅 | 3.1600 - 3.5900 |
| 52 週波幅 | 0.8010 - 9.6200 |
| 成交量 | |
| 平均成交量 | 2,241,768 |
| 市值 | 408.791M |
| Beta 值 (5 年，每月) | 1.51 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -1.4800 |
| 業績公佈日 | 2024年5月07日 - 2024年5月13日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 6.71 |
ZacksStrength Seen in Curis (CRIS): Can Its 19.5% Jump Turn into More Strength?
Curis (CRIS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Insider MonkeyMersana Therapeutics, Inc. (NASDAQ:MRSN) Q4 2023 Earnings Call Transcript
Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q4 2023 Earnings Call Transcript February 28, 2024 Mersana Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and welcome to the Mersana Therapeutics Fourth Quarter 2023 Conference Call and Webcast. Currently, all […]
ZacksMersana Therapeutics, Inc. (MRSN) Reports Q4 Loss, Lags Revenue Estimates
Mersana Therapeutics, Inc. (MRSN) delivered earnings and revenue surprises of 20% and 62.87%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
